These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Meta-analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography. Ukaigwe A; Karmacharya P; Mahmood M; Pathak R; Aryal MR; Jalota L; Donato AA Am J Cardiol; 2014 Nov; 114(9):1295-302. PubMed ID: 25239829 [TBL] [Abstract][Full Text] [Related]
24. Effect of short-term different statins loading dose on renal function and CI-AKI incidence in patients undergoing invasive coronary procedures. Han S; Li XM; Mohammed Ali LA; Fu NK; Jin DX; Cong HL Int J Cardiol; 2013 Oct; 168(5):5101-3. PubMed ID: 23972962 [No Abstract] [Full Text] [Related]
25. Statins use and the risk of acute kidney injury: a meta-analysis. Mao S; Huang S Ren Fail; 2014 May; 36(4):651-7. PubMed ID: 24502671 [TBL] [Abstract][Full Text] [Related]
26. The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials. Barbieri L; Verdoia M; Schaffer A; Nardin M; Marino P; De Luca G J Thromb Thrombolysis; 2014 Nov; 38(4):493-502. PubMed ID: 24705677 [TBL] [Abstract][Full Text] [Related]
27. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial). Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940 [TBL] [Abstract][Full Text] [Related]
28. Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: a systematic review and meta-analysis of randomized controlled trials. Cheungpasitporn W; Thongprayoon C; Kittanamongkolchai W; Edmonds PJ; O'Corragain OA; Srivali N; Ungprasert P; Erickson SB Ren Fail; 2015 May; 37(4):664-71. PubMed ID: 25703707 [TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830 [TBL] [Abstract][Full Text] [Related]
31. Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature. Prasad A; Ortiz-Lopez C; Khan A; Levin D; Kaye DM Catheter Cardiovasc Interv; 2016 Aug; 88(2):264-73. PubMed ID: 26946253 [TBL] [Abstract][Full Text] [Related]
32. Impact of Rosuvastatin in Contrast-Induced Acute Kidney Injury in the Elderly: Post Hoc Analysis of the PRATO-ACS Trial. Tropeano F; Leoncini M; Toso A; Maioli M; Dabizzi L; Biagini D; Villani S; Bellandi F J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):159-66. PubMed ID: 26307206 [TBL] [Abstract][Full Text] [Related]
33. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials. Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028 [TBL] [Abstract][Full Text] [Related]
34. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study. Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124 [TBL] [Abstract][Full Text] [Related]
35. Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study. Andò G; Cortese B; Frigoli E; Gagnor A; Garducci S; Briguori C; Rubartelli P; Calabrò P; Valgimigli M; Catheter Cardiovasc Interv; 2015 Nov; 86(5):950-7. PubMed ID: 25854692 [TBL] [Abstract][Full Text] [Related]
36. Additional data supporting the use of statins to prevent contrast induced nephropathy. Pappy R; Abu-Fadel MS Int J Cardiol; 2011 Oct; 152(2):265-6. PubMed ID: 21872353 [No Abstract] [Full Text] [Related]
37. Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography. Abaci O; Arat Ozkan A; Kocas C; Cetinkal G; Sukru Karaca O; Baydar O; Kaya A; Gurmen T Am J Cardiol; 2015 Apr; 115(7):867-71. PubMed ID: 25670636 [TBL] [Abstract][Full Text] [Related]
39. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). ACT Investigators Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972 [TBL] [Abstract][Full Text] [Related]